Using Magnetic Resonance Imaging to Evaluate Dendritic Cell-Based Vaccination

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Ferguson, Peter M ^a   Slocombe, Angela ^b   Tilley, Richard D ^c   Hermans, Ian F ^a  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b WELLINGTON HOSPITAL   (New Zealand)

^c VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; DENDRITIC CELL VACCINE; IMMUNOLOGICAL ADJUVANT; MAGNETIC IRON NANOPARTICLE; NANOPARTICLE; SERYLISOLEUCYLISOLEUCYLASPARAGINYLPHENYLALANYLGLUTAMYLLYSYLLEUCINE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELL HOMING; CELL MIGRATION; CELL THERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; GLIOMA CELL; IMMUNE RESPONSE; LYMPH NODE; LYMPHOCYTE; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; TREATMENT RESPONSE; VACCINATION;

ANIMALS; CANCER VACCINES; CELL LINE, TUMOR; DENDRITIC CELLS; IMMUNOTHERAPY, ADOPTIVE; IRON; LYMPH NODES; MAGNETIC RESONANCE IMAGING; METAL NANOPARTICLES; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; OUTCOME ASSESSMENT (HEALTH CARE); REPRODUCIBILITY OF RESULTS; VACCINATION;

EID: 84878459627     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065318     Document Type: Article

References (47)

1. Palucka K, Banchereau J, (2012) Cancer immunotherapy via dendritic cells. Nat Rev Cancer 12: 265-277.
2. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, et al. (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811.
3. Rosenberg SA, Yang JC, Restifo NP, (2004) Cancer immunotherapy: moving beyond current vaccines. Nat Med 10: 909-915.
4. Romero P, Cerottini JC, Speiser DE, (2004) Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination. Cancer Immunol Immunother 53: 249-255.
5. Hermans IF, Ritchie DS, Yang J, Roberts JM, Ronchese F, (2000) CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J Immunol 164: 3095-3101.
6. Yang J, Huck SP, McHugh RS, Hermans IF, Ronchese F, (2006) Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo. Proc Natl Acad Sci USA 103: 147-152.
7. R N Taub ARKDWD, (1970) The effect of localized injection of adjuvant material on the draining lymph node. Immunology 18: 171.
8. Frost P, (1974) Further evidence for the role of macrophages in the initiation of lymphocyte trapping. Immunology 27: 609-616.
9. Cahill RN, (1976) The effects of antigen on the migration of recirculating lymphocytes through single lymph nodes. J Exp Med 143: 870-888.
10. Zatz MM, (1976) Effects of BCG on lymphocyte trapping. J Immunol 116: 1587-1591.
11. Sprent J, Miller JF, Mitchell GF, (1971) Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol 2: 171-181.
12. Hurtenbach U, Gleichmann H, Nagata N, Gleichmann E, (1987) Immunity to D-penicillamine: genetic, cellular, and chemical requirements for induction of popliteal lymph node enlargement in the mouse. J Immunol 139: 411-416.
13. Baumjohann D, Hess A, Budinsky L, Brune K, Schuler G, et al. (2006) In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice. Eur J Immunol 36: 2544-2555.
14. de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, et al. (2005) Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 23: 1407-1413.
15. Kobukai S, Baheza R, Cobb JG, Virostko J, Xie J, et al. (2010) Magnetic nanoparticles for imaging dendritic cells. Mag Reson Med 63: 1383-1390.
16. Mou Y, Hou Y, Chen B, Hua Z, Zhang Y, et al. (2011) In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide. Int J Nanomedicine 6: 2633-2640.
17. Tavaré R, Sagoo P, Varama G, Tanriver Y, Warely A, et al. (2011) Monitoring of in vivo function of superparamagnetic iron oxide labelled murine dendritic cells during anti-tumour vaccination. PLoS ONE 6: e19662.
18. Verdijk P, Scheenen TW, Lesterhuis WJ, Gambarota G, Veltien AA, et al. (2007) Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int J Cancer 120: 978-984.
19. Zhang X, de Chickera SN, Willert C, Economopoulos V, Noad J, et al. (2011) Cellular magnetic resonance imaging of monocyte-derived dendritic cell migration from healthy donors and cancer patients as assessed in a scid mouse model. Cytotherapy 13: 1234-1248.
20. Cheong S, Ferguson P, Feindel KW, Hermans IF, Callaghan PT, et al. (2011) Simple synthesis and functionalization of iron nanoparticles for magnetic resonance imaging. Angew Chem Int Ed 50: 4206-4209.
21. Cheong S, Ferguson P, Hermans IF, Jameson G, Prabakar S, et al. (2012) Synthesis and stability of highly crystalline and stable iron/iron oxide core/shell nanoparticles for biomedical applications. ChemPlusChem 77: 135-140.
22. Herman DA, Ferguson P, Cheong S, Hermans IF, Ruck BJ, et al. (2011) Hot-injection synthesis of iron/iron oxide core/shell nanoparticles for T2 contrast enhancement in magnetic resonance imaging. Chem Commun 47: 9221-9223.
23. Ferguson PM, Feindel KW, Slocombe A, MacKay M, Wignall T, et al. (2013) Strongly Magnetic Iron Nanoparticles Improve the Diagnosis of Small Tumours in the Reticuloendothelial System by Magnetic Resonance Imaging. PLoS ONE 8(2): e56572.
24. Moore MW, Carbone FR, Bevan MJ, (1988) Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54: 777-785.
25. Lee A, Farrand KJ, Dickgreber N, Hayman CM, Jürs S, et al. (2006) Novel synthesis of α-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity. Carbohyd Res 341: 2785-2798.
26. Lutz MB, Kukutsch N, Ogilvie AL, Rössner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92.
27. Hermans I, Silk J, Yang J, Palmowski M, Gileadi U, et al. (2004) The vital assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J Immunol Methods 285: 25-40.
28. Pisanic TR, Blackwell JD, Shubayev VI, Fiñones RR, Jin S, (2007) Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomater 28: 2572-2581.
29. Fauconnier N, Pons J, Roger J, Bee A, (1997) Thiolation of Maghemite Nanoparticles by Dimercaptosuccinic Acid. J Colloid Interf Sci 194: 427-433.
30. Ritchie DS, Hermans IF, Lumsden JM, Scanga CB, Roberts JM, et al. (2000) Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo. J Immunol Methods 246: 109-117.
31. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, et al. (1997) CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides. Science 278: 1626-1629.
32. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM, (2003) Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 198: 267-279.
33. Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, et al. (2003) NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 171: 5140-5147.
34. Silk JD, Hermans IF, Gileadi U, Chong TW, Shepherd D, et al. (2004) Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J Clin Invest 114: 1800-1811.
35. Webster B, Ekland EH, Agle LM, Chyou S, Ruggieri R, et al. (2006) Regulation of lymph node vascular growth by dendritic cells. J Exp Med 203: 1903-1913.
36. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A, (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
37. Neller MA, Lopez JA, Schmidt CW, (2008) Antigens for cancer immunotherapy. Semin Immunol 20: 286-295.
38. Slingluff CL Jr, Yamshchikov GV, Hogan KT, Hibbitts SC, Petroni GR, et al. (2008) Evaluation of the sentinel immunized node for immune monitoring of cancer vaccines. Ann Surg Oncol 15: 3538-3549.
39. Medema JP, Schuurhuis DH, Rea D, van Tongeren J, de Jong J, et al. (2001) Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J Exp Med 194: 657-667.
40. Andrew KA, Simkins HM, Witzel S, Perret R, Hudson J, et al. (2008) Dendritic cells treated with lipopolysaccharide up-regulate serine protease inhibitor 6 and remain sensitive to killing by cytotoxic T lymphocytes in vivo. J Immunol 181: 8356-8362.
41. Mueller SN, Jones CM, Stock AT, Suter M, Heath WR, et al. (2006) CD4+ T cells can protect APC from CTL-mediated elimination. J Immunol 176: 7379-7384.
42. Matthews KE, Qin JS, Yang J, Hermans IF, Palmowski MJ, et al. (2007) Increasing the survival of dendritic cells in vivo does not replace the requirement for CD4+ T cell help during primary CD8+ T cell responses. J Immunol 179: 5738-5747.
43. Chung Y, Qin H, Kang CY, Kim S, Kwak LW, et al. (2007) An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity. Blood 110: 2013-2019.
44. Hong C, Lee H, Oh M, Kang CY, Hong S, et al. (2006) CD4+ T cells in the absence of the CD8+ cytotoxic T cells are critical and sufficient for NKT cell-dependent tumor rejection. J Immunol 177: 6747-6757.
45. Hunn MK, Farrand KJ, Broadley KWR, Weinkove R, Ferguson P, et al. (2012) Vaccination with irradiated tumor cells pulsed with an adjuvant that stimulates NKT cells is an effective treatment for glioma. Clin Cancer Res 18: 6446-6459.
46. Mumberg D, Monach PA, Wanderling S, Philip M, Toledano AY, et al. (1999) CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma. Proc Natl Acad Sci USA 96: 8633-8638.
47. Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, et al. (1996) Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183: 87-97.